Figure 3.

Policies on radical cure treatment for uncomplicated vivax malaria according to G6PD testing results in vivax endemic countries in the Asia-Pacific, the Horn of Africa and Madagascar, and the Americas. Treatment regimens are indicated by the country colour on the map. PQ treatment policies for G6PD normal, G6PD intermediate or mildly deficient, and G6PD deficient or severely deficient are shown in maps (A–C), respectively. bw = body weight. In Cambodia, G6PD normal individuals may also be given 0.75 mg/kg bw PQ weekly for 8 weeks. In Vanuatu and Panama, G6PD deficient individuals may also be given 0.75 mg/kg bw PQ weekly for 8 weeks, if access to supervision or blood transfusion is available.